Bone pain is a common symptom in multiple myeloma. Researchers are studying different ways to relieve myeloma-related bone pain. Results from a new clinical trial presented at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting show that a very low dose of radiation, given in just one or two quick visits, can safely ease bone pain without pausing your regular myeloma treatments.
Why multiple myeloma causes bone pain
Bone disease is one of the main complications of multiple myeloma. When abnormal plasma cells grow inside the bone marrow, they weaken the surrounding bone. This damage leads to painful bone lesions, increases the risk of broken bones (fractures), and can make everyday activities difficult.
What is palliative radiation therapy for multiple myeloma?
Multiple myeloma cells are extremely sensitive to radiation, making radiation therapy a well-known tool for shrinking painful areas of bone damage (called bone lesions). This is called palliative radiation therapy.
Even though radiation works well, doctors sometimes wait until pain becomes severe before recommending it. This is because radiation therapy can damage healthy cells, too. Care teams often worry that standard doses of radiation might harm healthy bone marrow or make it harder to schedule around a patient's ongoing myeloma medications.
What the new study found
Researchers across seven medical centers conducted a phase II clinical trial, to test whether a much smaller dose of radiation could still control bone pain. The study evaluated 63 patients with painful myeloma bone lesions.
Research shows that a radiation dose of 10 Gy causes problems with healthy blood cells. This study was designed to determine if a lower dose (4 Gy) could provide pain relief.
Key findings include:
Long-lasting relief: A very low dose of radiation eased pain for months, and 76% of patients achieved pain control without needing any extra radiation to that spot.
No treatment delays: Because the treatment takes only one or two days, patients did not have to interrupt their regular myeloma drugs.
Bone marrow protection: Using a lower dose limits damage to healthy bone marrow, keeping future treatment options open if new painful spots appear later.
No severe toxicity: There were no grade 3 or higher treatment related adverse events.
How much pain relief did patients get?
Patients tracked their pain levels and pain medication use at 4 weeks, 8 weeks, and 6 months after treatment:
At 4 weeks: 3 out of 5 patients reported pain relief, with an average pain reduction of 66% among those who completed follow-up surveys.
At 8 weeks: Average pain reduction remained steady at 64%.
At 6 months: 4 out of 5 patients reported pain relief, with an average pain reduction reaching 86%.
On average, it took about 36 days for patients to feel pain relief, and that relief lasted for a median of 148 days (nearly five months). Only 2419% of patients needed a second course of radiation to the same area, and among those who did, 63% experienced pain relief within four weeks.
What is ultra-low-dose radiation therapy?
Ultra-low-dose radiation uses a fraction of the radiation energy given in traditional treatments. In this study, patients received a total dose of 4 Gray (Gy), which is the standard unit used to measure radiation.
Doctors borrowed this idea from treating certain lymphomas, which are also very sensitive to radiation. The goal is to use just enough radiation to calm pain and target myeloma cells in the bone, while sparing healthy bone marrow and leaving room to safely give more radiation in the future if needed.
Radiation therapy side effects in myeloma
Because the dose is so low, only 4 out of 63 patients experienced mild-to-moderate tiredness. And only 1 patient reported mild skin irritation in the treated area.
Other radiation side effects from this type of therapy are fatigue, hairloss, nausea and vomiting, skin changes, diarrhea, urinary problems, fertility problems
What to expect during treatment
Ultra-low-dose radiation is designed to be quick and convenient. In the clinical trial, patients received their 4 Gy total dose in one of two ways:
One single treatment of 4 Gy
Two separate treatments of 2 Gy each
Both schedules gave patients the same level of pain relief. Because the sessions are brief and require minimal visits, this approach fits easily alongside systemic myeloma therapies like infusions, pills, or immunotherapy.
Who may not be a candidate
This ultra-low-dose approach was tested in patients with uncomplicated bone pain. It may not be the right choice if a bone lesion is causing an urgent medical problem, such as:
Spinal cord compression: When a tumor or weakened bone presses on the spinal cord.
Pathologic fracture: When a major weight-bearing bone (like a leg or arm bone) has already broken or is at immediate risk of breaking.
In those urgent situations, doctors typically recommend surgery, standard-dose radiation, or other immediate treatments to stabilize the bone.
Questions to ask your care team
If you are dealing with bone pain from multiple myeloma, consider bringing these questions to your next appointment:
Could ultra-low-dose radiation therapy help relieve my bone pain?
Would I be able to get this treatment without pausing my current myeloma medications?
How does this lower dose help protect my bone marrow for future therapies?
Are any of my bone lesions causing urgent issues like fractures or nerve pressure that need a different type of treatment?
Should I meet with a radiation oncologist earlier to discuss managing my bone pain?
Track your health with HealthTree!
Managing cancer care involves keeping track of lab results, fever trends, and infection histories across multiple appointments. Create a free HealthTree personal health record today to store all your medical records in one secure place, monitor your progress, and empower your care!
Source:

